A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/17329110

Bioorg. Med. Chem. 2007 Apr 15 15 8 2993-3002

Download in:

View as

General Info

PMID
17329110